Fig. 4: Metastases-free survival of patients stratified according to RlapsRisk BC classifier (left), Clinical score classifier (center), and RR Combined classifier (right) among patients from the CANTO intermediate clinical risk validation cohort. | Nature Communications

Fig. 4: Metastases-free survival of patients stratified according to RlapsRisk BC classifier (left), Clinical score classifier (center), and RR Combined classifier (right) among patients from the CANTO intermediate clinical risk validation cohort.

From: Deep learning assessment of metastatic relapse risk from digitized breast cancer histological slides

Fig. 4: Metastases-free survival of patients stratified according to RlapsRisk BC classifier (left), Clinical score classifier (center), and RR Combined classifier (right) among patients from the CANTO intermediate clinical risk validation cohort.The alternative text for this image may have been generated using AI.

p Values were computed using the two-sided log-rank test to compare survival distributions between groups. Shaded areas represent 95% confidence intervals estimated using the Greenwood formula.

Back to article page